BCOR and myelodysplastic syndrome: The carriers of somatic PIGA and BCOR/BCORL1 mutations show a lower risk of AA transformation to myelodysplastic syndrome (MDS), whereas myeloid driver lesions such as DNMT3A and ASXL1 mutations characterize the group with a higher risk of malignancy (18).